BOT
Click for more information
1.43% 34.5¢ botanix pharmaceuticals ltd

Ann: Botanix Placement Secures $13.5M to Fund Sofdra Launch Prep, page-14

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. FAnotTA
    4,173 Posts.
    lightbulb Created with Sketch. 554
    clock Created with Sketch.
    27/11/23
    09:59
    Post #: 71119321
    Where did I say approval?! I said SALES!!! Approvals out January if not sooner, meeting with 30 days Class A with FDA is this week. Hopefully more good news out end of week or so.
    Btw, I wouldn't be surprised BOT says mid 2024 so that they're covered in case but are accelerating the marketing push to be asap after approvals.
    The security raise, if anyone noticed, says 2,000,000 options expire at 2 years at 19.5c
    Last edited by FAnotTA: 27/11/23
    BOT Price at posting: 15.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SBW Shekel Brainweigh reports a 50% revenue increase in its Retail Innovation suite and delivers the first batch of 20 Smart Bays to Hitachi as part of a larger order
right-arrow Created with Sketch.
LGP Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
right-arrow Created with Sketch.
NEWS ClearVue successfully raises $7.5 million via institutional placement
right-arrow Created with Sketch.
NEWS Oversubscribed share purchase plan successfully raises $2.3 million, with all applications accepted in full
right-arrow Created with Sketch.
NVU Nanoveu commences crucial benchmark testing for System-on-aChip (SoC) Semiconductor technology
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.5¢ 		Change
-0.005(1.43%) 		Mkt cap ! $627.0M
Open High Low Value Volume
35.0¢ 36.0¢ 34.5¢ $1.255M 3.601M

Buyers (Bids)

No. Vol. Price($)
7 206282 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 316320 5
View Market Depth
Last trade - 16.10pm 18/10/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.